VR Logo

Glenmark Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1977

Chairman: Glenn Saldanha

Managing Director: Glenn Saldanha

Group: Glenmark

Listing: NSE: GLENMARK, BSE: 532296

Headquarters: Mumbai, Maharashtra

Website: www.glenmarkpharma.com

Key Facts

Market cap: R 13,202.65 Cr

Revenue (TTM): R 10,851.52 Cr

Earnings (TTM): R 956.52 Cr

Cash: R 1,111.24 Cr

Total Debt: R 4,868.63 Cr

Promoters' ownership: 46.63%

Liquidity: High

52 Week range: R 161.65 - 573.05

Face value: R1.00

Shares outstanding: 28,21,68,156

10 Years Aggregate:

  • CFO: 9,085.22 Cr
  • EBITDA: 13,000.10 Cr
  • Net Profit: 6,662.14 Cr

Stock Performance

Time Period Glenmark Pharma. S&P BSE Healthcare* S&P BSE Mid Cap*
YTD-5.18-2.1914.75
1 month-7.01-2.756.05
3 months-7.011.0918.40
1 Year61.0349.9141.29
3 Years-5.3214.978.08
5 Years-10.436.0215.01
10 Years4.5113.6812.05
As on 05-Mar-2021 *As on 07-Mar-2021
Year Glenmark Pharma. S&P BSE Mid Cap S&P BSE Healthcare
202042.7519.8761.45
2019-49.80-3.05-3.55
201816.43-13.31-5.89
2017-33.0648.130.49
2016-3.827.97-12.88
201518.887.4315.06
201445.2754.6947.43